Cargando…
PAFR selectively mediates radioresistance and irradiation-induced autophagy suppression in prostate cancer cells
Platelet-activating factor receptor (PAFR) promotes tumorigenesis, angiogenesis and metastasis. Here, we defined the PAFR as a yielding new inhibiting target to selectively enhance the sensitivity of prostate cancer (PCa) cells to radiation. The selective responding to PAFR inhibiter may be caused b...
Autores principales: | Yao, Bing, Liu, Bingqian, Shi, Lei, Li, Xiang, Ren, Chuanchuan, Cai, Mingbo, Wang, Wen, Li, Jianhua, Sun, Yongde, Wu, Yudong, Wen, Jianguo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355143/ https://www.ncbi.nlm.nih.gov/pubmed/28099922 http://dx.doi.org/10.18632/oncotarget.14647 |
Ejemplares similares
-
Emerging Roles of PAR-1 and PAFR in Melanoma Metastasis
por: Melnikova, Vladislava O., et al.
Publicado: (2008) -
Boosting Adaptive Immunity: A New Role for PAFR Antagonists
por: Koga, Marianna M., et al.
Publicado: (2016) -
Fluticasone propionate and increased risk of pneumonia in COPD: is it PAFR-dependent?
por: Sohal, Sukhwinder Singh
Publicado: (2017) -
Loss of PAFR prevents neuroinflammation and brain dysfunction after traumatic brain injury
por: Yin, Xiang-Jie, et al.
Publicado: (2017) -
Growth inhibition and differentiation of human breast cancer cells by the PAFR antagonist WEB-2086
por: Cellai, C, et al.
Publicado: (2006)